Jordi Rimola, MD PhD, is a consultant in the Radiology department at the Hospital Clinic of Barcelona, Barcelona, Spain. He is also a member of the Barcelona Clinic Liver Cancer (BCLC) Group. His main specialisation is in abdominal radiology, with a focus on liver cancer . In this setting, Dr Rimola has a specific interest in the early diagnosis of hepatocellular carcinoma (HCC) using non-invasive imaging techniques, characterisation of intrahepatic cholangiocarcinoma and its differentiation from HCC in patients with cirrhosis. In close collaboration with other members of the BCLC Group, Dr Rimola has also actively participated in the optimisation of functional imaging techniques, specifically perfusion computed tomography and liver-specific contrast agents, and the investigation of the potential role of this technique in the evaluation of the therapeutic response in patients with advanced HCC and for early detection of HCC recurrence. Results of his research have recently been published in peer-reviewed indexed journals. Dr Rimola is a member of the Spanish Society of Medical Radiology (SERAM), the European Society of Radiology (ESR) and the European Society of Abdominal and Gastroeintestinal Radiology (ESGAR). He is a reviewer for European Radiology, Journal of Hepatology and Gut, among others. Relevant publications Forner A, Ayuso C, Varela M, Rimola J, Hessheimer AJ, de Lope CR, Reig M, Bianchi L, Llovet JM, Bruix J. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer 2009 Feb 1; 115(3): 616-23. Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009; 50(3): 791-8. Vilana R, Forner A, Bianchi L, García-Criado A, Rimola J, de Lope CR, Reig M, Ayuso C, Brú C, Bruix J. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 2010 Jun; 51(6):2020-9. Tremosini S, Sole M, Forner A, Rodriguez de Lope, Rimola J, Reig M, Bianchi L, Vilana R, Ayuso C, Boix L, Bruix J. Prospective validation of the immunohistochemical panel (glypican 3, hea-shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut 2012; 61(10):1481-7 Rimola J, Forner A, Tremosini S, Reig M, Bianchi L, Rodríguez-Lope C, Solé M, Ayuso C, Bruix J. Non-Invasive diagnosis of Hepatocellular Carcinoma in cirrhosis. Accuracy assessing fat, capsule, and signal intensity at dynamic Magnetic Resonance. J Hepatol 2012;56(6):1317-23. Epub 2012 Feb 4. De Cecco CN, Darnell A, Macías N, Ayuso JR, Rodríguez S, Rimola J, Pagés M, García-Criado A, Rengo M, Laghi A, Ayuso C. Virtual Unenhanced Images of the Abdomen With Second-Generation Dual-Source Dual-Energy Computed Tomography: Image Quality and Liver Lesion Detection. Invest Radiol 2013;48(1):1-9. Reig M, Rimola J, Torres F, Darnell A, Lope CR, Forner A, Llarch N, Ríos J, Ayuso C, Bruix J. Post-progression survival of patients with advanced hepatocellular carcinoma. Rationale for second line trial design. Hepatology 2013 Dec;58(6):2023-31 Reig M, Torres F, Rodriguez-Lope C, Forner A, LLarch N, Rimola J, Darnell A, Ríos J, Ayuso C, Bruix J. Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib. J Hepatol 2014;61(2):318-24 Forner A, Vilana R, Bianchi L, Rodríguez-Lope C, Reig M, García-Criado MA, Rimola J, Solé M, Ayuso C, Bru C, Bruix J. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules < 2 cm. J Hepatol 2015 Jan;62(1):150-5 Darnell A, Forner A, Rimola J, Reig M, García-Criado Á, Ayuso C, Bruix J. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US. Radiology 2015;275(3):698-707. Rimola J, Díaz-González Á, Darnell A, Varela M, Pons F, Hernandez-Guerra M, Delgado M, Castroagudin J, Matilla A, Sangro B, de Lope CR, Sala M, Gonzalez C, Huertas C, Minguez B, Ayuso C, Bruix J, Reig M. Complete response under sorafenib in patients with hepatocellular carcinoma. Relationship with dermatologic adverse events. Hepatology 2017 Sep 12. doi: 10.1002/hep.29515. [Epub ahead of print] Llovet JM, Pavel M, Rimola J, Diaz MA, Colmenero J, Saavedra-Perez D, Fondevila C, Ayuso C, Fuster J, Ginès P, Bruix J, Garcia-Valdecasas JC. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria). Liver Transpl 2018 Mar;24(3):369-379. doi: 10.1002/lt.24977. Forner A, Rodríguez de Lope C, Reig M, Rimola J, Varela M. Early diagnosis of primary liver cancer – imaging versus genetics. Rev Esp Enfem Dig 2008, 100(7), 423-9. Real MI, Bianchi L, Vilana R, Burrel M, Rimola J. Percutaneous and Intra-arterial Treatment of Hepatocellular Carcinoma. Radiologia 2010;52(5):399-413 Ayuso C, Rimola J, Forner A. Imaging techniques in hepatocellular carcinoma: Diagnosis, extension and evaluation of therapeutic response. Gastroenterol Hepatol 2010;33(10):721-6 Ayuso C, Rimola J, García-Criado A. Imaging of Hepatocellular Carcinoma. Abdom Imaging 2012 Apr;37(2):215-30. Bruix J, Reig M, Rimola J, Forner A, Vilana R, Ayuso C. Clinical Decision Making and Research in Hepatocellular Carcinoma: Pivotal Role of Imaging Techniques. Hepatology 2011 Dec;54(6):2238-44. Forner A, Rimola J, Ayuso C. Conclusive HCC diagnosis with hepatocyte-specific contrast-enhanced magnetic resonance imaging? Not yet. J Hepatol 2016 Jun 14. pii: S0168-8278(16)30265-3. doi: 10.1016/j.jhep.2016.05.047.

Dr Jordi Rimola has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Roche.